| Methods |
Randomized
Double‐blind
Parallel‐group
Placebo‐controlled
Duration: 60 days |
| Participants |
Country: United States
No. of centers: 1
Diagnosis: Hospitalized patients with various diagnosis (chronic brain syndrome, cerebral arteriosclerosis, pre‐senile brain disease, arterial hypertension, involutional psychotic reaction, schizophrenic reaction, syphillis, Korsakoff).
Diagnosis defined by: "careful clinical assessment"
Total No. of patients: 28
Setting: Inpatient
Age: Median age= 66 (range= 56‐83)
Gender: 27 males, 1 female
Inclusion: hospitalized patients with various diagnosis (chronic brain syndrome, cerebral arteriosclerosis, pre‐senile brain disease, arterial hypertension, involutional psychotic reaction, schizophrenic reaction, syphillis, Korsakoff).
Exclusion: unclear |
| Interventions |
Route: sublingual
Treatment: Hydergine 30d= 1mg q.i.d., 15d= 1mg t.i.d., 15d= 1mg b.i.d.
Control: Placebo 30d= q.i.d., 15d= t.i.d., 15d= b.i.d. |
| Outcomes |
Hospital Adjustment Scale, physical examination, blood pressure, global rating |
| Notes |
No. excluded after randomization: Total = 2, Treatment = unclear, Control = unclear.
No. not included in analysis: Total = 2, Treatment = unclear, Control = unclear. |
